Literature DB >> 22472980

Progress in the development of hepatitis C virus vaccines.

Hildegund C J Ertl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22472980      PMCID： PMC3321602          DOI： 10.1038/mt.2012.30

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

1.  Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.

Authors:  H Chen; Z Q Xiang; Y Li; R K Kurupati; B Jia; A Bian; D M Zhou; N Hutnick; S Yuan; C Gray; J Serwanga; B Auma; P Kaleebu; X Zhou; M R Betts; H C J Ertl
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Authors:  Nia Tatsis; Julie C Fitzgerald; Arturo Reyes-Sandoval; Kimberly C Harris-McCoy; Scott E Hensley; Dongming Zhou; Shih-Wen Lin; Ang Bian; Zhi Quan Xiang; Amaya Iparraguirre; Cesar Lopez-Camacho; E John Wherry; Hildegund C J Ertl
Journal:  Blood       Date:  2007-05-17       Impact factor: 22.113

3.  A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

Authors:  Z Q Xiang; Y Yang; J M Wilson; H C Ertl
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

4.  Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus.

Authors:  Yan Zhi; Joanita Figueredo; Gary P Kobinger; Heather Hagan; Roberto Calcedo; James R Miller; Guangping Gao; James M Wilson
Journal:  Hum Gene Ther       Date:  2006-05       Impact factor: 5.695

5.  Chimpanzee-origin adenovirus vectors as vaccine carriers.

Authors:  N Tatsis; L Tesema; E R Robinson; W Giles-Davis; K McCoy; G P Gao; J M Wilson; H C J Ertl
Journal:  Gene Ther       Date:  2006-03       Impact factor: 5.250

Review 6.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

7.  Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys.

Authors:  Jinyan Liu; Bonnie A Ewald; Diana M Lynch; Matthew Denholtz; Peter Abbink; Angelique A C Lemckert; Angela Carville; Keith G Mansfield; Menzo J Havenga; Jaap Goudsmit; Dan H Barouch
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

8.  Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens.

Authors:  Nia Tatsis; Marcio O Lasaro; Shih-Wen Lin; Larissa H Haut; Zhi Q Xiang; Dongming Zhou; Lauren Dimenna; Hua Li; Ang Bian; Sarah Abdulla; Yan Li; Wynetta Giles-Davis; Jessica Engram; Sarah J Ratcliffe; Guido Silvestri; Hildegund C Ertl; Michael R Betts
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.

Authors:  Stefano Colloca; Eleanor Barnes; Antonella Folgori; Virginia Ammendola; Stefania Capone; Agostino Cirillo; Loredana Siani; Mariarosaria Naddeo; Fabiana Grazioli; Maria Luisa Esposito; Maria Ambrosio; Angela Sparacino; Marta Bartiromo; Annalisa Meola; Kira Smith; Ayako Kurioka; Geraldine A O'Hara; Katie J Ewer; Nicholas Anagnostou; Carly Bliss; Adrian V S Hill; Cinzia Traboni; Paul Klenerman; Riccardo Cortese; Alfredo Nicosia
Journal:  Sci Transl Med       Date:  2012-01-04       Impact factor: 17.956

10.  Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.

Authors:  Zhiquan Xiang; Yan Li; Ann Cun; Wei Yang; Susan Ellenberg; William M Switzer; Marcia L Kalish; Hildegund C J Ertl
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883
View more
  2 in total

Review 1.  State-of-the-art human gene therapy: part I. Gene delivery technologies.

Authors:  Dan Wang; Guangping Gao
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

2.  Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.

Authors:  Cody S Lee; Elliot S Bishop; Ruyi Zhang; Xinyi Yu; Evan M Farina; Shujuan Yan; Chen Zhao; Zongyue Zheng; Yi Shu; Xingye Wu; Jiayan Lei; Yasha Li; Wenwen Zhang; Chao Yang; Ke Wu; Ying Wu; Sherwin Ho; Aravind Athiviraham; Michael J Lee; Jennifer Moriatis Wolf; Russell R Reid; Tong-Chuan He
Journal:  Genes Dis       Date:  2017-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.